According to these findings, application of the LPWGS methods will be valuable in CIN evaluation and can serve as a novel prognosis factor to predict the clinical outcome in patients with BRCA1 mutation. The gene discussed is BRCA1; the disease is cervical squamous intraepithelial neoplasia.